Metreleptin Alternatives Compared
Metreleptin | Egrifta (tesamorelin) | Tesamorelin |
|
---|
Metreleptin | Egrifta (tesamorelin) | Tesamorelin |
|
|||||||
---|---|---|---|---|---|---|---|---|---|---|
Prescription only
Prescribed for Lipodystrophy. Metreleptin may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Lipodystrophy. Egrifta may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Lipodystrophy. Tesamorelin may also be used for purposes not listed in this medication guide. |
Related suggestions Lipodystrophy
|
|||||||
More about Metreleptin | More about Egrifta (tesamorelin) | More about Tesamorelin | ||||||||
Ratings & Reviews | ||||||||||
Be the first to share your experience with this drug. |
Egrifta has an average rating of 6.6 out of 10 from a total of 21 ratings on Drugs.com. 48% of reviewers reported a positive effect, while 14% reported a negative effect. |
Tesamorelin has an average rating of 6.7 out of 10 from a total of 23 ratings on Drugs.com. 48% of reviewers reported a positive effect, while 13% reported a negative effect. |
||||||||
Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||
View all Metreleptin side effects |
View all Egrifta side effects |
View all Tesamorelin side effects |
||||||||
Drug Class | ||||||||||
Generic Availability | ||||||||||
N/A |
N/A |
N/A |
||||||||
Pricing and Coupons * Prices are without insurance | ||||||||||
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Egrifta prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
Dosage Forms | ||||||||||
N/A |
|
N/A |
||||||||
Brand Names | ||||||||||
Myalept |
N/A |
Egrifta | ||||||||
Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||
4.7 hours |
0.63 hours |
0.63 hours |
||||||||
CSA Schedule 1 View glossary of CSA terms | ||||||||||
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
Pregnancy Category | ||||||||||
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
Category X
Not for use in pregnancy
See the full pregnancy warnings document. |
||||||||
Drug Interactions | ||||||||||
A total of 204 drugs are known to interact with Metreleptin:
|
A total of 48 drugs are known to interact with Egrifta:
|
A total of 48 drugs are known to interact with Tesamorelin:
|
||||||||
Alcohol/Food/Lifestyle Interactions | ||||||||||
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
Disease Interactions | ||||||||||
First Approval Date | ||||||||||
N/A |
N/A |
N/A |
||||||||
WADA Class View classifications | ||||||||||
N/A |
||||||||||
More Information | ||||||||||
Patient Resources | ||||||||||
Professional Resources | ||||||||||
Related Treatment Guide | ||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Egrifta
Egrifta (tesamorelin) is used to reduce excess fat around the stomach that is caused by taking ...
Myalept
Myalept (metreleptin) is used to treat complications caused by leptin deficiency in people who have ...
Ozempic
Learn about Ozempic (semaglutide) for type 2 diabetes treatment, weight management, cardiovascular ...
Amvuttra
Amvuttra is used to treat polyneuropathy associated with hereditary transthyretin-mediated ...
Aqneursa
Aqneursa information from Drugs.com, includes Aqneursa side effects, interactions and indications.
Cerdelga
Cerdelga (eliglustat) is used to treat mild to moderate Type 1 Gaucher Disease. Includes Cerdelga ...
Crysvita
Crysvita is used for familial hypophosphatemia, osteomalacia, X-Linked Hypophosphatemia
Galafold
Galafold (migalastat) is used to treat Fabry disease. Includes Galafold side effects, interactions ...
Givlaari
Givlaari injection is used for acute hepatic porphyria (AHP) to reduce the number of acute attacks ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.